Literature DB >> 30684916

IL-17 and colorectal cancer: From carcinogenesis to treatment.

Sepideh Razi1, Behnoud Baradaran Noveiry2, Mahsa Keshavarz-Fathi3, Nima Rezaei4.   

Abstract

Colorectal cancer (CRC) is one of the most common types of cancer in the world. Several factors contribute to the development of this cancer. Tumor formation in colon triggers immune responses such as immune cells proliferation, phenotype alteration, cytokine synthesis and release, which lead to IL-17 producing T cells, the differentiated CD4+ T cells i.e. T helper 17. IL-17 is a pro-inflammatory cytokine, which its level is up regulated in serum and tissues of CRC patients. Several studies have shown that IL-17 has an important role in metastasis and prognosis of CRC. The aim of this review is to summarize the role of this cytokine in tumorigenesis, angiogenesis and metastasis of CRC and discuss its value in diagnosis, prognosis and treatment of CRC.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Interleukin-17; Th17; Tumorigenesis; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2019        PMID: 30684916     DOI: 10.1016/j.cyto.2018.12.021

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  26 in total

1.  IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3.

Authors:  Xuefu Wang; Rui Sun; Xiaolei Hao; Zhe-Xiong Lian; Haiming Wei; Zhigang Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-12       Impact factor: 11.205

2.  Loss of Interleukin-17RA Expression is Associated with Tumour Progression in Colorectal Carcinoma.

Authors:  Boon Yean Chai; Wai Kien Yip; Noraini Dusa; Norhafizah Mohtarrudin; Heng Fong Seow
Journal:  Pathol Oncol Res       Date:  2020-05-27       Impact factor: 3.201

3.  IFNγ/PD-L1 Signaling Improves the Responsiveness of Anti-PD-1 Therapy in Colorectal Cancer: An in vitro Study.

Authors:  Wenli Yuan; Deyao Deng; Hanyu Li; Xinghui Hu; Xueqin Shang; Xia Hou; Hongchao Jiang; Hongchun He
Journal:  Onco Targets Ther       Date:  2021-05-07       Impact factor: 4.147

Review 4.  Intestinal microbiota: a new force in cancer immunotherapy.

Authors:  Zhujiang Dai; Jingqiu Zhang; Qi Wu; Huiwen Fang; Chunfeng Shi; Zhen Li; Chaobiao Lin; Dong Tang; Daorong Wang
Journal:  Cell Commun Signal       Date:  2020-06-10       Impact factor: 5.712

Review 5.  TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer.

Authors:  Guanglin Cui
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

6.  Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis.

Authors:  Amy I Yu; Lili Zhao; Kathryn A Eaton; Sharon Ho; Jiachen Chen; Sara Poe; James Becker; Allison Gonzalez; Delaney McKinstry; Muneer Hasso; Jonny Mendoza-Castrejon; Joel Whitfield; Charles Koumpouras; Patrick D Schloss; Eric C Martens; Grace Y Chen
Journal:  Cell Rep       Date:  2020-04-07       Impact factor: 9.423

7.  Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis.

Authors:  Charlotte Girondel; Kim Lévesque; Marie-Josée Langlois; Sarah Pasquin; Marc K Saba-El-Leil; Nathalie Rivard; Robert Friesel; Marc J Servant; Jean-François Gauchat; Sylvie Lesage; Sylvain Meloche
Journal:  Oncogene       Date:  2020-11-11       Impact factor: 9.867

Review 8.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

Review 9.  Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.

Authors:  Bilikis Aderonke Abolarinwa; Ridwan Babatunde Ibrahim; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

10.  Identification and Verification of Core Genes in Colorectal Cancer.

Authors:  Houxi Xu; Yuzhu Ma; Jinzhi Zhang; Jialin Gu; Xinyue Jing; Shengfeng Lu; Shuping Fu; Jiege Huo
Journal:  Biomed Res Int       Date:  2020-05-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.